You just read:

BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor® Use in Invossa™ Osteoarthritis Cell-Mediated Gene Therapy

News provided by

BioLife Solutions, Inc.

Dec 20, 2016, 06:00 ET